[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @d_stock07734 d_stock d_stock posts on X about $nwbo, $mrk, $1b, mayo the most. They currently have XXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours. ### Engagements: XXXXX [#](/creator/twitter::1660707117722902539/interactions)  - X Week XXXXXX -XX% - X Month XXXXXX +207% - X Months XXXXXX +20% - X Year XXXXXXX +19% ### Mentions: X [#](/creator/twitter::1660707117722902539/posts_active)  ### Followers: XXX [#](/creator/twitter::1660707117722902539/followers)  - X Week XXX no change - X Month XXX +2.70% - X Months XXX +20% - X Year XXX +6.90% ### CreatorRank: XXXXXXX [#](/creator/twitter::1660707117722902539/influencer_rank)  ### Social Influence [#](/creator/twitter::1660707117722902539/influence) --- **Social category influence** [stocks](/list/stocks) [finance](/list/finance) **Social topic influence** [$nwbo](/topic/$nwbo), [$mrk](/topic/$mrk), [$1b](/topic/$1b), [mayo](/topic/mayo), [syringes](/topic/syringes), [os](/topic/os), [dominance](/topic/dominance), [plug](/topic/plug), [ammo](/topic/ammo), [$300m](/topic/$300m) **Top assets mentioned** [Merck & Co., Inc. (MRK)](/topic/$mrk) ### Top Social Posts [#](/creator/twitter::1660707117722902539/posts) --- Top posts by engagements in the last XX hours "@ttubular @andrewcaravello Merger will make Merck have dominance. Let all BPs compete with each other and cancer patients can get the most benefit"  [@d_stock07734](/creator/x/d_stock07734) on [X](/post/tweet/1949487189727048062) 2025-07-27 15:09:00 UTC XXX followers, XX engagements "Indeed the 63A building at Merck West Point Campus can produce vaccines that can protect individuals against diseases and related cancers. What type of related cancers can be the targets It would be really cool if the cancers are related to the trials conducted by Mayo Clinic The 63A project was initiated in December 2020 to provide a facility to house a multi-product syringe filling line that will deliver the safe compliant and reliable annual production of XX million pre-filled syringes. The project will increase doses of vaccines by adding drug product capacity at the Merck PA"  [@d_stock07734](/creator/x/d_stock07734) on [X](/post/tweet/1947736183980888442) 2025-07-22 19:11:08 UTC XXX followers, 1216 engagements "Simply taking a look at the titles of the trials can we see pneumococcal conjugate vaccine from Merck was added to the combination This can give us a hint on how the relevant parties want to keep low profile of these trials. Tumor should melt away if both Keytruda and Prenvar13 were combined with the Direct. Dendritic Cell Therapy With Pembrolizumab for Metastatic or Unresectable Melanoma Study Start (Actual): 2017-11-15 Primary Completion (Actual): 2020-06-14 Principal Investigator:Matthew S. Block M.D. Ph.D.Mayo Clinic Phase Ib/II Study of Autologous Dendritic Cell Therapy Delivered"  [@d_stock07734](/creator/x/d_stock07734) on [X](/post/tweet/1949209544124399738) 2025-07-26 20:45:44 UTC XXX followers, XXX engagements "Merck's pneumococcal vaccines are stored in pre-filled syringes. Prevnar XX (Pneumococcal 20-valent Conjugate Vaccine): This vaccine is available in a pre-filled syringe format. Prevnar XX (Pneumococcal 13-valent Conjugate Vaccine): This vaccine is supplied in single-dose pre-filled syringes. Pneumovax XX (Pneumococcal Vaccine Polyvalent): This vaccine is available in both single-dose vials and single-dose pre-filled syringes It is interesting Merck added another building 63A next to the manufacturing building XX for pneumococcal vaccines which was completed before 2021. Three DC therapy"  [@d_stock07734](/creator/x/d_stock07734) on [X](/post/tweet/1947673856187007105) 2025-07-22 15:03:28 UTC XXX followers, 1786 engagements "@Laser1227 @andrewcaravello Actually it is great to see that Baker Brothers and Merck are focusing on the same thing complementary to DCVax"  [@d_stock07734](/creator/x/d_stock07734) on [X](/post/tweet/1948608424075239711) 2025-07-25 04:57:06 UTC XXX followers, XX engagements "Building XX at Merck West Point Campus is another vaccine manufacturing facility for vaccines. It must be the kind of vaccine that Merck considers so important that many extra working hours have to be taken to complete the building in a hurry. How much does Merck have to pay for working extra hours at PA I didn't see Merck had the same kind of passion to solve BCG shortage issue. The vaccine from B50 cannot be Gardasil since Merck had expansion at Elkton. It cannot be PCV either since B63 & B63A buildings are for PCV manufacturing. So far Merck hasn't released any PR on the vaccine"  [@d_stock07734](/creator/x/d_stock07734) on [X](/post/tweet/1948147319779578200) 2025-07-23 22:24:50 UTC XXX followers, XXX engagements "@biosectinvestor I was trying to supply FeMike some ammo that he can use for his bear agenda. He keeps ignoring me. He is smart isn't he"  [@d_stock07734](/creator/x/d_stock07734) on [X](/post/tweet/1948804968867397642) 2025-07-25 17:58:06 UTC XXX followers, XX engagements "@mazzulo_lorie @andrewcaravello Is it interesting that Merck spent $300m acquiring Immune Design for its TLR4 agonist while skipping Oncovir"  [@d_stock07734](/creator/x/d_stock07734) on [X](/post/tweet/1947044394881699973) 2025-07-20 21:22:12 UTC XXX followers, XXX engagements "@biosectinvestor Did you predict that Merck's deal with Daiichi is about Daiichi's CSF1R inhibitor"  [@d_stock07734](/creator/x/d_stock07734) on [X](/post/tweet/1948394650915520574) 2025-07-24 14:47:38 UTC XXX followers, XX engagements "Forget about the prediction $NWBO will be a trillion-dollar company. Merck only made less than $1b from Prenvar13 vaccine. Merck will be the first trillion-dollar BP once keytruda Prenvar13 and TLR4 are combined with the DC vaccine therapy. Dendritic Cell Therapy With Pembrolizumab for Metastatic or Unresectable Melanoma Study Start (Actual): 2017-11-15 Primary Completion (Actual): 2020-06-14 Principal Investigator:Matthew S. Block M.D. Ph.D.Mayo Clinic Phase Ib/II Study of Autologous Dendritic Cell Therapy Delivered Intratumorally After Cryoablation in Combination With Pembrolizumab for"  [@d_stock07734](/creator/x/d_stock07734) on [X](/post/tweet/1949204769085820958) 2025-07-26 20:26:46 UTC XXX followers, 3026 engagements "See these trials on tough stage IV cancers conducted by Mayo clinic Can you see explicitly that pneumococcal vaccine was included in the combination You may do forensic analysis on all the published results related to all these trials in which Merck was involved indirectly. $NWBO has not done any trials of these types. The message is clear. If these trials had nothing to do with $NWBO's technology $NWBO would be out of business once Merck releases official PR on its collaboration with Mayo. But this scenario would never happen. You know how desperately the shorts want to suffocate the company"  [@d_stock07734](/creator/x/d_stock07734) on [X](/post/tweet/1948617621739303268) 2025-07-25 05:33:39 UTC XXX followers, XX engagements "The analysis on building XX at Merck West Point Campus is stunning Poly-iclc manufacturing involves lyophilization in case someone still has doubt. Scalable production of polyribonucleotides of controlled size"  [@d_stock07734](/creator/x/d_stock07734) on [X](/post/tweet/1948100449833296265) 2025-07-23 19:18:35 UTC XXX followers, 1783 engagements "They are trying hard to contain the spread of the information. If you ask Grok about the successful p3 trial on dendritic cell vaccines Grok cannot give you the right answer because Grok collects the data from the information polluted by those who are against this revolutionary treatment disrupting their current business model"  [@d_stock07734](/creator/x/d_stock07734) on [X](/post/tweet/1945493094264193395) 2025-07-16 14:37:53 UTC XXX followers, XXX engagements "Just curious about the number of drugs Merck can contribute as complementary to DCVax products. Merck has TLR4 keytruda pneumococcal conjugate vaccines for sure. Merck also conducted phase 1/2 trials on TLR3 agonist TLR9 agonist IL-2 super-agonist IL-12 agonist Il-15 super-agonist A2A/A2B adenosine receptor antagonist STING agonist retinoic acid-inducible gene I (RIG-I) agonist IL-10 agonist NLRP3 Inhibitor MDM2 inhibitor Activin signaling inhibitor. TGF-beta inhibitor GLP-1/glucagon receptor co-agonist TIGIT inhibitor Nectin-4 inhibitor Anti-LAG-3 monoclonal antibody HIF-2 inhibitor"  [@d_stock07734](/creator/x/d_stock07734) on [X](/post/tweet/1947714218431598658) 2025-07-22 17:43:51 UTC XXX followers, XXX engagements "Absolutely brilliant post. Here is the job posting from Merck three years ago. It seems like the manufacturing facilities that Merck was trying to construct at Merck West Point Campus are just pilot models that Merck intend to reproduce in other locations too. Simply going through all the following three Direct-like trials and taking a look at the combination adopted how could anyone still have doubt Read again the grant description submitted by Mill Creek Life Sciences. In the last a couple of years they have been building alleogeneic tumor lysate library for other types of solid tumors"  [@d_stock07734](/creator/x/d_stock07734) on [X](/post/tweet/1948069221511868610) 2025-07-23 17:14:30 UTC XXX followers, 1136 engagements "Another acquisition by Merck that can tackle immunosuppresion due to tumor-associated neutrophils. Thanks @andrewcaravello"  [@d_stock07734](/creator/x/d_stock07734) on [X](/post/tweet/1948496922513158442) 2025-07-24 21:34:02 UTC XXX followers, XXX engagements "Such a fabulous detect work Thanks @andrewcaravello Merck first completed the building XX for Pneumococcal Conjugate Vaccine and the project even won an excellence reward. The interesting part is that right after the completion of the building XX Merck added building 63A with the manufacturing capacity over 70m pre-filled syringes. Is there a huge market demand for PCV Take a look at the hectic working hours Merck adopted to complete 63A. Why did Merck try to finish the construction in such a hurry The 63A project was initiated in December 2020 to provide a facility to house a multi-product"  [@d_stock07734](/creator/x/d_stock07734) on [X](/post/tweet/1948098128332345582) 2025-07-23 19:09:22 UTC XXX followers, XXX engagements "I cannot say Merck is innovative given that after spending billions of dollars trying to find a replacement for keytruda all Merck can do is to change the delivery mode of the drug. But using Winterfell as the code name for Building XX is creative"  [@d_stock07734](/creator/x/d_stock07734) on [X](/post/tweet/1949149260479340693) 2025-07-26 16:46:11 UTC XXX followers, XXX engagements "The longs should know that what Merck has been trying to accomplish over the past many years through acquisitions and collaborations: Building an empire complementary to DCVax. But Merck does have competitors"  [@d_stock07734](/creator/x/d_stock07734) on [X](/post/tweet/1948465062726787250) 2025-07-24 19:27:26 UTC XXX followers, XXX engagements "A DC vaccine therapy trial conducted by Mayo Clinic. Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer Results As of July XX 2022 eight subjects have enrolled (5 HCC; X iCCA) with five (3 HCC; X iCCA) having completed the protocol and three (2 HCC; X iCCA) currently in active phase. DC manufacturing success has been XXX% and the maximal dose of XX x XXX DC appears to be tolerated without autoimmunity or grade X adverse events (AEs) with the exception of one subject with"  [@d_stock07734](/creator/x/d_stock07734) on [X](/post/tweet/1949677214720540959) 2025-07-28 03:44:05 UTC XXX followers, 1990 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@d_stock07734 d_stock
d_stock posts on X about $nwbo, $mrk, $1b, mayo the most. They currently have XXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours.
Engagements: XXXXX #
- X Week XXXXXX -XX%
- X Month XXXXXX +207%
- X Months XXXXXX +20%
- X Year XXXXXXX +19%
Mentions: X #
Followers: XXX #
- X Week XXX no change
- X Month XXX +2.70%
- X Months XXX +20%
- X Year XXX +6.90%
CreatorRank: XXXXXXX #
Social Influence #
Social category influence stocks finance
Social topic influence $nwbo, $mrk, $1b, mayo, syringes, os, dominance, plug, ammo, $300m
Top assets mentioned Merck & Co., Inc. (MRK)
Top Social Posts #
Top posts by engagements in the last XX hours
"@ttubular @andrewcaravello Merger will make Merck have dominance. Let all BPs compete with each other and cancer patients can get the most benefit"
@d_stock07734 on X 2025-07-27 15:09:00 UTC XXX followers, XX engagements
"Indeed the 63A building at Merck West Point Campus can produce vaccines that can protect individuals against diseases and related cancers. What type of related cancers can be the targets It would be really cool if the cancers are related to the trials conducted by Mayo Clinic The 63A project was initiated in December 2020 to provide a facility to house a multi-product syringe filling line that will deliver the safe compliant and reliable annual production of XX million pre-filled syringes. The project will increase doses of vaccines by adding drug product capacity at the Merck PA" @d_stock07734 on X 2025-07-22 19:11:08 UTC XXX followers, 1216 engagements
"Simply taking a look at the titles of the trials can we see pneumococcal conjugate vaccine from Merck was added to the combination This can give us a hint on how the relevant parties want to keep low profile of these trials. Tumor should melt away if both Keytruda and Prenvar13 were combined with the Direct. Dendritic Cell Therapy With Pembrolizumab for Metastatic or Unresectable Melanoma Study Start (Actual): 2017-11-15 Primary Completion (Actual): 2020-06-14 Principal Investigator:Matthew S. Block M.D. Ph.D.Mayo Clinic Phase Ib/II Study of Autologous Dendritic Cell Therapy Delivered" @d_stock07734 on X 2025-07-26 20:45:44 UTC XXX followers, XXX engagements
"Merck's pneumococcal vaccines are stored in pre-filled syringes. Prevnar XX (Pneumococcal 20-valent Conjugate Vaccine): This vaccine is available in a pre-filled syringe format. Prevnar XX (Pneumococcal 13-valent Conjugate Vaccine): This vaccine is supplied in single-dose pre-filled syringes. Pneumovax XX (Pneumococcal Vaccine Polyvalent): This vaccine is available in both single-dose vials and single-dose pre-filled syringes It is interesting Merck added another building 63A next to the manufacturing building XX for pneumococcal vaccines which was completed before 2021. Three DC therapy" @d_stock07734 on X 2025-07-22 15:03:28 UTC XXX followers, 1786 engagements
"@Laser1227 @andrewcaravello Actually it is great to see that Baker Brothers and Merck are focusing on the same thing complementary to DCVax" @d_stock07734 on X 2025-07-25 04:57:06 UTC XXX followers, XX engagements
"Building XX at Merck West Point Campus is another vaccine manufacturing facility for vaccines. It must be the kind of vaccine that Merck considers so important that many extra working hours have to be taken to complete the building in a hurry. How much does Merck have to pay for working extra hours at PA I didn't see Merck had the same kind of passion to solve BCG shortage issue. The vaccine from B50 cannot be Gardasil since Merck had expansion at Elkton. It cannot be PCV either since B63 & B63A buildings are for PCV manufacturing. So far Merck hasn't released any PR on the vaccine" @d_stock07734 on X 2025-07-23 22:24:50 UTC XXX followers, XXX engagements
"@biosectinvestor I was trying to supply FeMike some ammo that he can use for his bear agenda. He keeps ignoring me. He is smart isn't he" @d_stock07734 on X 2025-07-25 17:58:06 UTC XXX followers, XX engagements
"@mazzulo_lorie @andrewcaravello Is it interesting that Merck spent $300m acquiring Immune Design for its TLR4 agonist while skipping Oncovir" @d_stock07734 on X 2025-07-20 21:22:12 UTC XXX followers, XXX engagements
"@biosectinvestor Did you predict that Merck's deal with Daiichi is about Daiichi's CSF1R inhibitor" @d_stock07734 on X 2025-07-24 14:47:38 UTC XXX followers, XX engagements
"Forget about the prediction $NWBO will be a trillion-dollar company. Merck only made less than $1b from Prenvar13 vaccine. Merck will be the first trillion-dollar BP once keytruda Prenvar13 and TLR4 are combined with the DC vaccine therapy. Dendritic Cell Therapy With Pembrolizumab for Metastatic or Unresectable Melanoma Study Start (Actual): 2017-11-15 Primary Completion (Actual): 2020-06-14 Principal Investigator:Matthew S. Block M.D. Ph.D.Mayo Clinic Phase Ib/II Study of Autologous Dendritic Cell Therapy Delivered Intratumorally After Cryoablation in Combination With Pembrolizumab for" @d_stock07734 on X 2025-07-26 20:26:46 UTC XXX followers, 3026 engagements
"See these trials on tough stage IV cancers conducted by Mayo clinic Can you see explicitly that pneumococcal vaccine was included in the combination You may do forensic analysis on all the published results related to all these trials in which Merck was involved indirectly. $NWBO has not done any trials of these types. The message is clear. If these trials had nothing to do with $NWBO's technology $NWBO would be out of business once Merck releases official PR on its collaboration with Mayo. But this scenario would never happen. You know how desperately the shorts want to suffocate the company" @d_stock07734 on X 2025-07-25 05:33:39 UTC XXX followers, XX engagements
"The analysis on building XX at Merck West Point Campus is stunning Poly-iclc manufacturing involves lyophilization in case someone still has doubt. Scalable production of polyribonucleotides of controlled size" @d_stock07734 on X 2025-07-23 19:18:35 UTC XXX followers, 1783 engagements
"They are trying hard to contain the spread of the information. If you ask Grok about the successful p3 trial on dendritic cell vaccines Grok cannot give you the right answer because Grok collects the data from the information polluted by those who are against this revolutionary treatment disrupting their current business model" @d_stock07734 on X 2025-07-16 14:37:53 UTC XXX followers, XXX engagements
"Just curious about the number of drugs Merck can contribute as complementary to DCVax products. Merck has TLR4 keytruda pneumococcal conjugate vaccines for sure. Merck also conducted phase 1/2 trials on TLR3 agonist TLR9 agonist IL-2 super-agonist IL-12 agonist Il-15 super-agonist A2A/A2B adenosine receptor antagonist STING agonist retinoic acid-inducible gene I (RIG-I) agonist IL-10 agonist NLRP3 Inhibitor MDM2 inhibitor Activin signaling inhibitor. TGF-beta inhibitor GLP-1/glucagon receptor co-agonist TIGIT inhibitor Nectin-4 inhibitor Anti-LAG-3 monoclonal antibody HIF-2 inhibitor" @d_stock07734 on X 2025-07-22 17:43:51 UTC XXX followers, XXX engagements
"Absolutely brilliant post. Here is the job posting from Merck three years ago. It seems like the manufacturing facilities that Merck was trying to construct at Merck West Point Campus are just pilot models that Merck intend to reproduce in other locations too. Simply going through all the following three Direct-like trials and taking a look at the combination adopted how could anyone still have doubt Read again the grant description submitted by Mill Creek Life Sciences. In the last a couple of years they have been building alleogeneic tumor lysate library for other types of solid tumors" @d_stock07734 on X 2025-07-23 17:14:30 UTC XXX followers, 1136 engagements
"Another acquisition by Merck that can tackle immunosuppresion due to tumor-associated neutrophils. Thanks @andrewcaravello" @d_stock07734 on X 2025-07-24 21:34:02 UTC XXX followers, XXX engagements
"Such a fabulous detect work Thanks @andrewcaravello Merck first completed the building XX for Pneumococcal Conjugate Vaccine and the project even won an excellence reward. The interesting part is that right after the completion of the building XX Merck added building 63A with the manufacturing capacity over 70m pre-filled syringes. Is there a huge market demand for PCV Take a look at the hectic working hours Merck adopted to complete 63A. Why did Merck try to finish the construction in such a hurry The 63A project was initiated in December 2020 to provide a facility to house a multi-product" @d_stock07734 on X 2025-07-23 19:09:22 UTC XXX followers, XXX engagements
"I cannot say Merck is innovative given that after spending billions of dollars trying to find a replacement for keytruda all Merck can do is to change the delivery mode of the drug. But using Winterfell as the code name for Building XX is creative" @d_stock07734 on X 2025-07-26 16:46:11 UTC XXX followers, XXX engagements
"The longs should know that what Merck has been trying to accomplish over the past many years through acquisitions and collaborations: Building an empire complementary to DCVax. But Merck does have competitors" @d_stock07734 on X 2025-07-24 19:27:26 UTC XXX followers, XXX engagements
"A DC vaccine therapy trial conducted by Mayo Clinic. Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer Results As of July XX 2022 eight subjects have enrolled (5 HCC; X iCCA) with five (3 HCC; X iCCA) having completed the protocol and three (2 HCC; X iCCA) currently in active phase. DC manufacturing success has been XXX% and the maximal dose of XX x XXX DC appears to be tolerated without autoimmunity or grade X adverse events (AEs) with the exception of one subject with" @d_stock07734 on X 2025-07-28 03:44:05 UTC XXX followers, 1990 engagements